# UGT8

## Overview
UGT8 (UDP glycosyltransferase 8) is a gene that encodes the enzyme UDP glycosyltransferase 8, which is a member of the glycosyltransferase family. This enzyme is primarily involved in the biosynthesis of galactosylceramide, a crucial component of the myelin sheath in the nervous system, and plays a significant role in the galactosidation of bile acids. UGT8 is predominantly localized in the endoplasmic reticulum, where it facilitates the transfer of galactose to ceramide, forming galactosylceramide, which is essential for maintaining myelin integrity and proper nerve conduction (Meech2019The). Beyond its enzymatic functions, UGT8 is implicated in various cellular processes, including interactions with other proteins and regulatory non-coding RNAs, which may influence cancer progression and drug resistance (Liu2023The; Hu2021Circular). The gene's expression levels have been associated with different cancer types, affecting tumor growth, metastasis, and patient prognosis, highlighting its potential as a prognostic biomarker and therapeutic target (Liu2023The; Dziȩgiel2010Ceramide).

## Structure
UGT8 (UDP glycosyltransferase 8) is a protein involved in the galactosidation of ceramides and bile acids. The primary structure of UGT8 consists of 541 amino acids, as obtained from the UniProt database (Meech2014A). The protein has a molecular mass in the range of 50-60 kDa (Meech2014A). 

The secondary structure of UGT8 includes motifs associated with the endoplasmic reticulum membrane, which are crucial for its localization and function (Meech2014A). The tertiary structure of UGT8 features a glycosyltransferase domain, which is responsible for its enzymatic activity. Structural modeling based on the UGT2B7CT crystal structure suggests a highly homologous binding pocket for UDP-sugars, which is essential for its substrate specificity (Meech2014A).

UGT8 may form homodimers, indicating a quaternary structure, although specific details on this aspect are not extensively covered in the available literature. Common post-translational modifications of UGT8 include glycosylation and phosphorylation, which may influence its activity and stability. The presence of splice variant isoforms could potentially alter its function or localization, although specific variants are not detailed in the context provided.

## Function
UGT8 (UDP glycosyltransferase 8) is an enzyme that plays a crucial role in the biosynthesis of galactosylceramide (GalCer), a key component of the myelin sheath in the nervous system. It catalyzes the transfer of galactose to ceramide, forming GalCer, which is essential for maintaining the structural integrity and function of myelin, thereby facilitating proper nerve conduction (Meech2019The). UGT8 is primarily active in the endoplasmic reticulum, where it interacts with the UDP-galactose transporter SLC35A2 to enhance galactosylceramide production (Hu2019The).

In addition to its role in the nervous system, UGT8 is involved in the galactosidation of bile acids, a process that may influence bile acid metabolism and signaling in the gastrointestinal tract and kidney (Meech2014A; Meech2019The). This activity suggests a broader function for UGT8 in modulating bile acid homeostasis and signaling pathways, potentially impacting the microbiome and intestinal signaling (Meech2019The). UGT8's activity is highly conserved across species, indicating its fundamental role in physiological processes (Meech2019The).

## Clinical Significance
UGT8 is implicated in various cancers, with its expression levels influencing tumor progression and patient prognosis. In breast cancer, high UGT8 expression is associated with increased malignancy and lung metastases, particularly in ER-negative tumors. This elevated expression correlates with higher tumor grades and is linked to shorter lung metastasis-free survival (Dziȩgiel2010Ceramide). UGT8 also plays a role in basal breast cancer cells by enhancing malignancy, with high expression linked to poor prognosis (Liu2023The).

In lung cancer, UGT8 maintains tissue malignancy and is associated with drug resistance and metastasis, leading to poor prognosis (Liu2023The). It is upregulated in non-small cell lung cancer, where it enhances glycolysis, impacting cancer cell metabolism and tumor growth (Liu2023The).

UGT8 expression is elevated in colon, esophageal, and gastric cancers, where it is positively associated with good prognosis (Liu2023The). In uveal melanoma, UGT8 is linked to poor overall survival rates, suggesting its potential as a prognostic biomarker (Hu2021The).

Mutations in UGT8 may affect cancer cell metabolism and drug resistance, with significant mutations identified across various cancer types (Hu2022The). UGT8's role in ceramide metabolism is linked to drug resistance, as it helps cancer cells survive by converting ceramide to galactosylceramide, reducing ceramide-induced apoptosis (Liu2023The).

## Interactions
UGT8 (UDP glycosyltransferase 8) is known to interact with various proteins and participate in cellular processes. It is generally localized to the endoplasmic reticulum but has been found to physically interact with a Golgi-localized UDP-Gal transporter. This interaction suggests that UGT8 may play a role in modulating protein galactosidation events in both the endoplasmic reticulum and Golgi apparatus (Meech2019The). UGT8 also interacts with the UDP-galactose transporter SLC35A2, which is crucial for protein galactosylation in the Golgi. This interaction may influence protein galactosylation by potentially relocalizing the transporter from the Golgi to the endoplasmic reticulum (Meech2019The).

In addition to protein interactions, UGT8 circRNAs may function as regulatory non-coding RNAs by sponging specific microRNAs (miRNAs), such as miR-214-3p, which is involved in tumor proliferation and chemotherapy resistance. This suggests a potential role for UGT8 circRNAs in impacting the survival of patients with triple-negative breast cancer (Hu2021Circular). These interactions indicate that UGT8 may have a broader role in cellular signaling and regulation beyond its enzymatic functions.


## References


[1. (Liu2023The) Wenyu Liu, Jing Li, Rui Zhao, Yao Lu, and Panpan Huang. The uridine diphosphate (udp)-glycosyltransferases (ugts) superfamily: the role in tumor cell metabolism. Frontiers in Oncology, January 2023. URL: http://dx.doi.org/10.3389/fonc.2022.1088458, doi:10.3389/fonc.2022.1088458. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.1088458)

[2. (Dziȩgiel2010Ceramide) P Dziȩgiel, T Owczarek, E Plaz̀uk, A Gomułkiewicz, M Majchrzak, M Podhorska-Okołów, K Driouch, R Lidereau, and M Ugorski. Ceramide galactosyltransferase (ugt8) is a molecular marker of breast cancer malignancy and lung metastases. British Journal of Cancer, 103(4):524–531, July 2010. URL: http://dx.doi.org/10.1038/sj.bjc.6605750, doi:10.1038/sj.bjc.6605750. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6605750)

[3. (Hu2021The) Dong Gui Hu, Shashikanth Marri, Peter I. Mackenzie, Julie-Ann Hulin, Ross A. McKinnon, and Robyn Meech. The expression profiles and deregulation of udp-glycosyltransferase (ugt) genes in human cancers and their association with clinical outcomes. Cancers, 13(17):4491, September 2021. URL: http://dx.doi.org/10.3390/cancers13174491, doi:10.3390/cancers13174491. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13174491)

[4. (Meech2014A) Robyn Meech, Nurul Mubarokah, Aravind Shivasami, Anne Rogers, Pramod C. Nair, Dong Gui Hu, Ross A. McKinnon, and Peter I. Mackenzie. A novel function for udp glycosyltransferase 8: galactosidation of bile acids. Molecular Pharmacology, 87(3):442–450, December 2014. URL: http://dx.doi.org/10.1124/mol.114.093823, doi:10.1124/mol.114.093823. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.114.093823)

[5. (Hu2022The) Dong Gui Hu, Shashikanth Marri, Julie-Ann Hulin, Ross A. McKinnon, Peter I. Mackenzie, and Robyn Meech. The somatic mutation landscape of udp-glycosyltransferase (ugt) genes in human cancers. Cancers, 14(22):5708, November 2022. URL: http://dx.doi.org/10.3390/cancers14225708, doi:10.3390/cancers14225708. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers14225708)

[6. (Hu2021Circular) Dong Gui Hu, Peter I. Mackenzie, Julie-Ann Hulin, Ross A. McKinnon, and Robyn Meech. Circular rnas of udp-glycosyltransferase (ugt) genes expand the complexity and diversity of the ugt transcriptome. Molecular Pharmacology, 99(6):488–503, April 2021. URL: http://dx.doi.org/10.1124/molpharm.120.000225, doi:10.1124/molpharm.120.000225. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/molpharm.120.000225)

[7. (Hu2019The) Dong Gui Hu, J.ulie-Ann Hulin, Pramod C. Nair, Alex Z. Haines, Ross A. McKinnon, Peter I. Mackenzie, and Robyn Meech. The ugtome: the expanding diversity of udp glycosyltransferases and its impact on small molecule metabolism. Pharmacology &amp; Therapeutics, 204:107414, December 2019. URL: http://dx.doi.org/10.1016/j.pharmthera.2019.107414, doi:10.1016/j.pharmthera.2019.107414. This article has 36 citations.](https://doi.org/10.1016/j.pharmthera.2019.107414)

[8. (Meech2019The) Robyn Meech, Dong Gui Hu, Ross A. McKinnon, Siti Nurul Mubarokah, Alex Z. Haines, Pramod C. Nair, Andrew Rowland, and Peter I. Mackenzie. The udp-glycosyltransferase (ugt) superfamily: new members, new functions, and novel paradigms. Physiological Reviews, 99(2):1153–1222, April 2019. URL: http://dx.doi.org/10.1152/physrev.00058.2017, doi:10.1152/physrev.00058.2017. This article has 272 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00058.2017)